This company has been marked as potentially delisted and may not be actively trading. FTD Companies (FTD) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock FTD Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period AviadoBio begins Phase I/II trial of FTD-GRN gene therapy in the UKMay 16, 2025 | msn.comCoya Therapeutics Reports First Quarter Financial Results and Provides a Corporate UpdateMay 14, 2025 | finance.yahoo.comAviadoBio Announces Completion of Second Cohort in Phase 1/2 ASPIRE-FTD Clinical Trial Studying AVB-101 for FTD-GRNMay 2, 2025 | morningstar.comMBest FTD coupon and discount codes we've tested in March 2025March 20, 2025 | businessinsider.comCEO Spotlight: Orhan Ural on Steering a Prime Brokerage FirmJanuary 24, 2025 | msn.comOppenheimer maintains Dyne stock Outperform with $60 targetJanuary 21, 2025 | msn.comBiotechnology Company Psilera Convenes Prominent Industry Leaders & Patient Advocates for First FTD Research SummitJanuary 15, 2025 | finance.yahoo.comWendy Williams is ‘permanently incapacitated’ amid dementia battle, guardian revealsNovember 28, 2024 | msn.comCervoMed Stock Surges On FDA Orphan Drug Nod For FTD Treatment: Retail Optimism RekindledNovember 27, 2024 | msn.comCervoMed Says FDA Grants Orphan Drug Designation For Neflamapimod In Frontotemporal DementiaNovember 27, 2024 | markets.businessinsider.comPassage Bio Advances PBFT02 Gene Therapy Program Amidst Positive Q3 2024 ResultsNovember 15, 2024 | msn.comPassage Bio’s Strong Financial Position and Clinical Progress Justify Buy RatingNovember 15, 2024 | markets.businessinsider.comQuanterix Corporation (NASDAQ:QTRX) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | msn.comPassage Bio Reports Third Quarter 2024 Financial Results and Provides Recent Business HighlightsNovember 13, 2024 | markets.businessinsider.comGenascence Granted FDA Fast Track Designation for GNSC-001 in Patients with Osteoarthritis (OA) of the KneeNovember 12, 2024 | finance.yahoo.comTransposon to Present Results from Phase 2 Study of TPN-101 for the Treatment of C9orf72-Related ALS/FTD at the 7th Annual ALS ONE Research SymposiumNovember 6, 2024 | finance.yahoo.comCoya Therapeutics: Buying The Dip After Unwarranted Sell-OffOctober 31, 2024 | seekingalpha.comGenelux: 2nd Half Of 2025 PRROC Data Is Major Inflection PointOctober 31, 2024 | seekingalpha.comCisco issues emergency fix for VPN tool, users told to update nowOctober 25, 2024 | msn.comSpinal Muscular Atrophy Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and BarriersOctober 23, 2024 | theglobeandmail.comFPL aims for Sarasota, Manatee counties to have power by ThursdayOctober 12, 2024 | msn.comWe want to make a difference - brothersOctober 7, 2024 | msn.comAnti CD70 Antibodies Clinical Trials FDA Approval CD70 Cancer Therapies Clinical Trials Market Opportunity InsightOctober 5, 2024 | finance.yahoo.combit.bio to Unveil iPSC Advancements and ioCells Toolkit at Society for Neuroscience 2024 Annual ConferenceSeptember 30, 2024 | finance.yahoo.comIntroducing AI Exchange: what does the future hold for the fast-evolving technology?September 27, 2024 | ft.comPublishing Global Industry Almanac 2024: Key Financial Metrics and Analysis of Competitive Pressures 2019-2028September 24, 2024 | finance.yahoo.comFinancière de Tubize SA (FTD.F) Stock Price, News, Quote & History - Yahoo FinanceSeptember 24, 2024 | finance.yahoo.comQurAlis Announces Expansion of its Selective Kv7.2/7.3 Ion Channel Opener, QRL-101, Into EpilepsySeptember 19, 2024 | sg.finance.yahoo.comPassage Bio Shares Promising Data on PBFT02 for Frontotemporal DementiaSeptember 19, 2024 | msn.comWendy Williams only paid $82K for doc as guardian accuses creators of taking ‘advantage’ of a ‘severely impaired’ person: lawsuitSeptember 18, 2024 | nypost.comNPsilocybin Drug By Psilera Could Treat Frontotemporal Dementia Without Psychoactive EffectsSeptember 9, 2024 | benzinga.comSun Pharma and Moebius gain FDA fast track for osteoarthritis drugSeptember 9, 2024 | msn.comDow Jones Futures Rise: Will Apple iPhone 16 Give Bulls A Ring? Palantir, Dell Jump. (Live Coverage)September 9, 2024 | msn.comDow Jones Futures Fall: Will Apple iPhone 16 Give Bulls A Ring? Palantir, Dell Jump (Live Coverage)September 8, 2024 | msn.comDow Jones Futures Due: Apple iPhone 16 Looms, Palantir, Dell Jump, Tesla-xAI In FocusSeptember 8, 2024 | msn.comTD Cowen Sticks to Its Buy Rating for Alector (ALEC)September 7, 2024 | markets.businessinsider.comUSF Research Foundation Proudly Endorses and Invests in Psilera's FTD ResearchSeptember 6, 2024 | finance.yahoo.comVesper Bio reports data from Phase I frontotemporal dementia treatment trialSeptember 5, 2024 | finance.yahoo.comDow Jones Futures: Market Rally At Key Levels; Tesla, Nvidia Are Key MoversSeptember 4, 2024 | msn.comInnovent Gets Fast Track Designation From FDA For IBI363 As Monotherapy For Advanced MelanomaSeptember 3, 2024 | nasdaq.comDow Jones Futures: Record Nvidia Sell-Off Fuels Market Expectations Breaker; What To Do NowSeptember 3, 2024 | msn.comAcuraStem Secures $4 Million in Grant Funding from CIRM to Advance UNC13A Program for ALS and FTDSeptember 3, 2024 | finance.yahoo.comWendy Williams Makes Rare Public Appearance at New Jersey StoreAugust 30, 2024 | msn.comRemeGen Co Ltd (REG.DU)August 28, 2024 | uk.finance.yahoo.comPsilera receives positive preclinical in vivo data for frontotemporal dementia (FTD) candidate, PSIL-006August 27, 2024 | finance.yahoo.comFTD Limited’s Insights: How to Select the Best Liquidity ProviderAugust 22, 2024 | msn.comfabric Expands Executive Team Amidst Strong Company and Customer GrowthAugust 22, 2024 | markets.businessinsider.comQurAlis to Participate in Upcoming Investor and Industry Conferences in SeptemberAugust 21, 2024 | finance.yahoo.comTheriva™ Biologics Reports Second Quarter 2024 Operational Highlights and Financial ResultsAugust 13, 2024 | finance.yahoo.comRegistrational Phase III Study of Lisaftoclax in Newly-Diagnosed Patients with Higher-Risk Myelodysplastic Syndrome Cleared by China CDEAugust 13, 2024 | msn.com Get FTD Companies News Delivered to You Automatically Sign up to receive the latest news and ratings for FTD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FTD Media Mentions By Week FTD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FTD News Sentiment▼0.000.87▲Average Consumer Discretionary News Sentiment FTD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FTD Articles This Week▼01▲FTD Articles Average Week Get the Latest News and Ratings for FTD and Related Stocks Enter your email address to receive the latest news and analysts' ratings for FTD Companies and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies MCOM News LUXH News GPAK News BMR News NFLX News DIS News SONY News CMCSA News NKE News RCL News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FTD) was last updated on 8/26/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredTrump’s SHOCKING Plan to Create MASSIVE Wealth for AmericansJames Altucher says Donald Trump just made a move so surprising, it could go down as the most lucrative presid...Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredNew Federal Land Rush About to Start?A $100 Trillion Wealth Shift Is Already Underway Lithium. Oil. Gold. Trillions in U.S. resources are being ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FTD Companies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share FTD Companies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access